CDER-167

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameCDER-167
Drug Alias NameCDER-167
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSphingosine kinase 1 inhibitorsUric acid transporter 1 inhibitors
TargetsUric acid transporter 1
Therapy Area/IndicationsHyperuricemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperuricemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A